K36 Therapeutics

Translating epigenetic modulation of oncogenic pathways into first-in-class small molecule therapeutics

Headquarters Cambridge, MA
Website https://www.k36tx.com/
Pipeline Status Preclinical
LinkedIn K36 Therapeutics